checkAd

     181  0 Kommentare Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update - Seite 3

    In summary, I would like to extend my sincere gratitude to all of our shareholders that have stood by as we pushed through these monumental hurdles. We have not reached the end of the road yet, but the achievement of our vision is in sight. Moving into 2024, Milestone is focused on increasing the number of CompuFlo providers in the US to further advance clinical utilization of the CompuFlo technology. In addition, we remain committed to accelerating patient access to this technology through ongoing education and engagement with payors to attain consistent coverage and reimbursement for this clinically valuable procedure. We look forward to a number of exciting developments in the months and years ahead and plan to keep investors fully apprised of our progress.

    Regards,
    Arjan Haverhals

    About Milestone Scientific Inc.

    Milestone Scientific Inc. (MLSS) is a biomedical technology company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and devices for medical and dental use. Since inception, Milestone Scientific has engaged in pioneering proprietary, innovative, computer-controlled injection technologies, and solutions for the medical and dental markets.

    Milestone Scientific has developed a proprietary, revolutionary, computer-controlled anesthetic delivery device, our DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration – enabling healthcare practitioners to achieve multiple unique benefits that cannot currently be accomplished with the 160-year-old manual syringe. The company’s proprietary DPS Dynamic Pressure Sensing technology is a technology platform that advances the development of next-generation devices. It regulates flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, used in various dental and medical injections. It has specific medical applications for epidural space identification in regional anesthesia procedures. To learn more, view the MLSS brand video or visit milestonescientific.com.

    Seite 3 von 4



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update - Seite 3 Reports initial reimbursements of CompuFlo by commercial payors and MedicareROSELAND, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) - Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless …